human papilloma virus

(International Union Against Cancer) Recent advances in cervical cancer prevention mean that controlling the disease in developing countries is becoming feasible for the first time, experts say.

Developments such as highly effective vaccines against the human papilloma virus (HPV) and promising new screening tests provide an unprecedented opportunity to tackle the disease in poor countries, where pap smear screening has largely failed because it is too expensive and too complicated to implement.

Teenage girls who are sexually active and those who are not eventually all have the same risk for infection with the human papilloma virus (HPV), new research suggests.